Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins.
about
Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsAlginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of DoxorubicinNMR and ESR study of liposome delivery of Mn2+ to murine liver.Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles.Porphyrin-phospholipid liposomes with tunable leakiness.Entrapment of human leukocyte interferon in the aqueous interstices of liposomes.Lipophilic drug transfer between liposomal and biological membranes: what does it mean for parenteral and oral drug delivery?An interdisciplinary computational/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicity.Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate.Cancer drug delivery in the nano era: An overview and perspectives (Review)Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.The in vitro transfer of [14C]dimyristoylphosphatidylcholine from liposomes to subfractions of human plasma high density lipoproteins as resolved by isoelectric focusing.Amphotericin B and its delivery by liposomal and lipid formulations.Temperature-sensitive liposome-mediated delivery of thrombolytic agents.Liposomal doxorubicin.Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo.On the size-dependent disintegration of small unilamellar phosphatidylcholine vesicles in rat plasma. Evidence of complete loss of vesicle structure.Pharmacokinetic characterization of phosphatidylserine liposomes in the rat.Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factorsTargeting of liposomes to accessible cells in vivo.The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.Liposomes for use in gene deliveryStability of liposomes in circulation is markedly enhanced by structural modification of their phospholipid component.Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitroFine-tuning of POPC liposomal leakage by the use of beta-cyclodextrin and several hydrophobic guests.A comparison of fluorescence methods used in the pharmacokinetic studies of Zn(II)phthalocyanine in mice.Localized drug delivery using crosslinked gelatin gels containing liposomes: factors influencing liposome stability and drug release.Plasma-induced release of solutes from small unilamellar liposomes is associated with pore formation in the bilayers.Quantitative In Vitro Assessment of Liposome Stability and Drug Transfer Employing Asymmetrical Flow Field-Flow Fractionation (AF4).Elimination of liposomes by different separation principles used in low-density lipoprotein apheresis.Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling.Characterization of drug release from liposomal formulations in ocular fluid.Loading antimalarial drugs into noninfected red blood cells: an undesirable roommate for Plasmodium.Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction.New methodology for liposome targeting to specific cells.Targeted Delivery of Protein Drugs by Nanocarriers.
P2860
Q26996159-7C34BBE3-BBA2-45EB-B859-258098F899DAQ28550901-3BBDFF46-F0BD-47D0-BC42-09F3AF06E371Q33899700-83073A63-12CE-4D8A-9A04-58EE6B94894FQ35602780-FE62B1B2-E9C7-4F8D-AFFA-AC304FC97CA3Q35844575-D9CD7694-672B-4AAD-A967-BD40056CE024Q36445018-31B4F50D-8FF0-4361-BE68-A94139EBC5F2Q36585620-4C8B265D-96FF-4D75-AA2B-053F617EF083Q37013368-745B661F-3482-4DAE-85ED-82D7DB1A0D69Q37605346-CA215F21-92DD-4349-98EA-C77FA94E9D63Q38669454-E2FAA4FF-C559-4A0F-929A-E77902E6C448Q38689437-35F57DF5-13EC-4ED6-83E8-9F46F7EE6A90Q40259196-B0E00067-7BBC-45B8-BDDF-5E3610834FA1Q40831603-A2D458B6-E13F-4AF9-B08C-2B5B11D9D9F2Q41136821-586BCD8C-5512-413A-8AAF-F7DF3D609EB2Q41262422-FE3DF1AA-33CB-46C3-8EB1-6EB3BAF983E3Q41496883-E56C6B2B-B20D-4F18-BD83-60146E849606Q41858235-EC458C3B-9D57-45F7-AD78-5754ECC60DCAQ41965364-66504CBE-E075-438D-B52D-558FBE88E88CQ41976699-E0CF569F-B3AE-4D9A-A1ED-E8E5D581C012Q41992036-4A4C5CF3-0B1D-47D8-B4DF-FC067F245808Q42011060-C4050640-3407-444E-9A85-12B8EA548C3AQ42183122-9EF8CB3E-6546-4B58-81DF-8FCAB2454552Q42259024-373E71D3-A604-46BB-BDAE-B9331CF3395DQ42746832-D23DEC86-4A97-4CB3-A428-3CA7C607691BQ43256748-9FBA0175-5227-490E-9087-8DA17E2CCA96Q44019714-F66F383A-E3CF-431D-AE26-8BF5F885FB2DQ45078260-628EEAC9-F158-480A-A54B-67DD86322A29Q46596892-3194F5A5-B63D-46C0-B2CA-16CFE87AB41EQ46635086-12FCF6C1-5E0D-4E82-A945-3D2E2F3EA223Q46766432-2B7F2157-F09C-4615-B024-3E0719DFE7DFQ47361973-A2F0B383-BA6F-4826-88BB-1A295E92B4BBQ47833709-A51DB01C-3AA3-49E6-8E47-F5A97A7F28F6Q47917198-38FADBF3-EE13-443D-8855-B25DF515E358Q48788158-174DE105-E938-40AF-A453-73B0C85F9512Q54462699-104028B1-5A73-429F-AD78-64C0647B74B7Q54647504-1C218A75-4DBA-4370-8D94-78C80CD31714
P2860
Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Disintegration of phosphatidyl ...... ith high-density lipoproteins.
@en
type
label
Disintegration of phosphatidyl ...... ith high-density lipoproteins.
@en
prefLabel
Disintegration of phosphatidyl ...... ith high-density lipoproteins.
@en
P2093
P1476
Disintegration of phosphatidyl ...... ith high-density lipoproteins.
@en
P2093
P304
P356
10.1016/0304-4165(78)90025-9
P577
1978-08-01T00:00:00Z